Alembic Pharmaceuticals Ltd. - Research Center
533573 APLLTD Group (A) BSE data
Add to watchlist
| Results |
Quarterly
|
| Statement | |
| More |
Quarterly results in brief
(Rs crore)
| Mar' 24 | Dec' 23 | Sep' 23 | Jun' 23 | Mar' 23 | |
|---|---|---|---|---|---|
| Sales | 1,474.55 | 1,588.39 | 1,478.84 | 1,332.27 | 1,307.12 |
| Operating profit | 288.19 | 337.14 | 207.46 | 165.73 | 169.18 |
| Interest | 10.13 | 14.66 | 15.39 | 14.29 | 13.59 |
| Gross profit | 285.28 | 325.78 | 201.03 | 163.28 | 157.55 |
| EPS (Rs) | 10.27 | 11.87 | 6.81 | 4.96 | 6.64 |
Quarterly
results in details
| Mar' 24 | Dec' 23 | Sep' 23 | Jun' 23 | Mar' 23 | |
|---|---|---|---|---|---|
| Other income | 7.22 | 3.30 | 8.95 | 11.84 | 1.96 |
| Stock adjustment | -25.25 | 10.15 | -30.07 | -7.20 | 44.03 |
| Raw material | 337.38 | 317.58 | 413.87 | 334.19 | 313.34 |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 354.92 | 327.11 | 326.41 | 327.47 | 297.40 |
| Excise | - | - | - | - | - |
| Admin and selling expenses | - | - | - | - | - |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 519.31 | 596.41 | 561.18 | 512.09 | 483.17 |
| Provisions made | - | - | - | - | - |
| Depreciation | 69.12 | 69.08 | 67.18 | 65.75 | 73.54 |
| Taxation | 14.29 | 23.46 | - | - | -46.53 |
| Net profit / loss | 201.87 | 233.24 | 133.84 | 97.53 | 130.54 |
| Extra ordinary item | - | - | - | - | - |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 39.31 | 39.31 | 39.31 | 39.31 | 39.31 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | - | - | - | - | - |
| Agg.of non promotoholding (%) | - | - | - | - | - |
| OPM (%) | 19.54 | 21.23 | 14.03 | 12.44 | 12.94 |
| GPM (%) | 19.25 | 20.47 | 13.51 | 12.15 | 12.04 |
| NPM (%) | 13.62 | 14.65 | 9.00 | 7.26 | 9.97 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis